Pfizer Inc Unclassified
FDA Approved Drugs
Pfizer Inc Unclassified
FDA Approved Drugs Database
FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.
- Total Records 35
- Latest Approval Date -
- Data Source FDA
- First Approval Date -
Company Overview
Social Profiles
Company Snapshot
FDA Approved Drug Records ( 35 records )
Drug Name
ABRILADA
Product Number
1
Dosage Form
-
Strength
40MG/0.8ML
Approval Date
-
Active Ingredient
ADALIMUMAB-AFZB
Application Number
761118
Product Number
1
Dosage Form
-
Strength
40MG/0.8ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ABRILADA
Product Number
2
Dosage Form
-
Strength
20MG/0.4ML
Approval Date
-
Active Ingredient
ADALIMUMAB-AFZB
Application Number
761118
Product Number
2
Dosage Form
-
Strength
20MG/0.4ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ABRILADA
Product Number
3
Dosage Form
-
Strength
10MG/0.2ML
Approval Date
-
Active Ingredient
ADALIMUMAB-AFZB
Application Number
761118
Product Number
3
Dosage Form
-
Strength
10MG/0.2ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ALBAMYCIN
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE
Approval Date
-
Active Ingredient
NOVOBIOCIN SODIUM
Application Number
50339
Product Number
1
Dosage Form
-
Strength
EQ 250MG BASE
Approval Date
-
Regulatory Status
Unclassified
Drug Name
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Product Number
7
Dosage Form
-
Strength
10MG; 40MG
Approval Date
-
Active Ingredient
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
Application Number
78466
Product Number
7
Dosage Form
-
Strength
10MG; 40MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
AZULFIDINE
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
-
Active Ingredient
SULFASALAZINE
Application Number
20465
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
Product Number
1
Dosage Form
-
Strength
50MG/300MG/300MG
Approval Date
-
Active Ingredient
DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Application Number
212303
Product Number
1
Dosage Form
-
Strength
50MG/300MG/300MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
DOLUTEGRAVIR;LAMIVUDINE;TENOFOVIR ALAFENAMIDE
Product Number
1
Dosage Form
-
Strength
50MG;300MG;25MG
Approval Date
-
Active Ingredient
DOLUTEGRAVIR;LAMIVUDINE;TENOFOVIR ALAFENAMIDE
Application Number
215187
Product Number
1
Dosage Form
-
Strength
50MG;300MG;25MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ELASE-CHLOROMYCETIN
Product Number
1
Dosage Form
-
Strength
10MG/GM;666 UNITS/GM;1 UNITS/GM
Approval Date
-
Active Ingredient
CHLORAMPHENICOL; DESOXYRIBONUCLEASE; FIBRINOLYSIN
Application Number
50294
Product Number
1
Dosage Form
-
Strength
10MG/GM;666 UNITS/GM;1 UNITS/GM
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ELELYSO
Product Number
1
Dosage Form
-
Strength
200 UNITS/VIAL
Approval Date
-
Active Ingredient
TALIGLUCERASE ALFA
Application Number
22458
Product Number
1
Dosage Form
-
Strength
200 UNITS/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ELREXFIO
Product Number
1
Dosage Form
-
Strength
12MG
Approval Date
-
Active Ingredient
ELRANATAMAB
Application Number
761345
Product Number
1
Dosage Form
-
Strength
12MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ERAXIS
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
-
Active Ingredient
ANIDULAFUNGIN
Application Number
21948
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
HYMPAVZI
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
-
Active Ingredient
MARSTACIMAB-HNCQ
Application Number
761369
Product Number
1
Dosage Form
-
Strength
300MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
IXIFI
Product Number
1
Dosage Form
-
Strength
100MG/VIAL
Approval Date
-
Active Ingredient
INFLIXIMAB-QBTX
Application Number
761072
Product Number
1
Dosage Form
-
Strength
100MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
NEOSPORIN G.U. IRRIGANT
Product Number
2
Dosage Form
-
Strength
EQ 800MG BASE/20ML;4,000,000 UNITS/20ML (EQ 40MG BASE/ML;200,000 UNITS/ML)
Approval Date
-
Active Ingredient
NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Application Number
60707
Product Number
2
Dosage Form
-
Strength
EQ 800MG BASE/20ML;4,000,000 UNITS/20ML (EQ 40MG BASE/ML;200,000 UNITS/ML)
Approval Date
-
Regulatory Status
Unclassified
Drug Name
NEURONTIN
Product Number
1
Dosage Form
-
Strength
250MG/5ML
Approval Date
-
Active Ingredient
GABAPENTIN
Application Number
21216
Product Number
1
Dosage Form
-
Strength
250MG/5ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
NEURONTIN
Product Number
1
Dosage Form
-
Strength
600MG
Approval Date
-
Active Ingredient
GABAPENTIN
Application Number
21397
Product Number
1
Dosage Form
-
Strength
600MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
NEURONTIN
Product Number
1
Dosage Form
-
Strength
800MG
Approval Date
-
Active Ingredient
GABAPENTIN
Application Number
21423
Product Number
1
Dosage Form
-
Strength
800MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
NEURONTIN
Product Number
1
Dosage Form
-
Strength
250MG/5ML
Approval Date
-
Active Ingredient
GABAPENTIN
Application Number
21424
Product Number
1
Dosage Form
-
Strength
250MG/5ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
NGENLA
Product Number
1
Dosage Form
-
Strength
24MG
Approval Date
-
Active Ingredient
SOMATROGON-GHLA
Application Number
761184
Product Number
1
Dosage Form
-
Strength
24MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
NGENLA
Product Number
2
Dosage Form
-
Strength
60MG
Approval Date
-
Active Ingredient
SOMATROGON-GHLA
Application Number
761184
Product Number
2
Dosage Form
-
Strength
60MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
PAXLOVID (COPACKAGED)
Product Number
2
Dosage Form
-
Strength
300MG;100MG
Approval Date
-
Active Ingredient
NIRMATRELVIR; RITONAVIR
Application Number
217188
Product Number
2
Dosage Form
-
Strength
300MG;100MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
RUXIENCE
Product Number
1
Dosage Form
-
Strength
100MG/10ML(10MG/ML)
Approval Date
-
Active Ingredient
RITUXIMAB-PVVR
Application Number
761103
Product Number
1
Dosage Form
-
Strength
100MG/10ML(10MG/ML)
Approval Date
-
Regulatory Status
Unclassified
Drug Name
RUXIENCE
Product Number
2
Dosage Form
-
Strength
500MG/50ML(10MG/ML)
Approval Date
-
Active Ingredient
RITUXIMAB-PVVR
Application Number
761103
Product Number
2
Dosage Form
-
Strength
500MG/50ML(10MG/ML)
Approval Date
-
Regulatory Status
Unclassified
Drug Name
SYNERCID
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
-
Active Ingredient
QUINUPRISTIN; DALFOPRISTIN
Application Number
50747
Product Number
1
Dosage Form
-
Strength
500MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
TRAZIMERA
Product Number
1
Dosage Form
-
Strength
420MG
Approval Date
-
Active Ingredient
TRASTUZUMAB-QYYP
Application Number
761081
Product Number
1
Dosage Form
-
Strength
420MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
VFEND
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
-
Active Ingredient
VORICONAZOLE
Application Number
21464
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
VFEND
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
-
Active Ingredient
VORICONAZOLE
Application Number
21464
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
VFEND
Product Number
3
Dosage Form
-
Strength
200MG
Approval Date
-
Active Ingredient
VORICONAZOLE
Application Number
21464
Product Number
3
Dosage Form
-
Strength
200MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
VFEND
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
-
Active Ingredient
VORICONAZOLE
Application Number
21466
Product Number
1
Dosage Form
-
Strength
50MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
VFEND
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
-
Active Ingredient
VORICONAZOLE
Application Number
21466
Product Number
2
Dosage Form
-
Strength
200MG
Approval Date
-
Regulatory Status
Unclassified
Drug Name
VFEND
Product Number
3
Dosage Form
-
Strength
200MG/VIAL
Approval Date
-
Active Ingredient
VORICONAZOLE
Application Number
21466
Product Number
3
Dosage Form
-
Strength
200MG/VIAL
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ZIRABEV
Product Number
1
Dosage Form
-
Strength
100MG/4ML
Approval Date
-
Active Ingredient
BEVACIZUMAB-BVZR
Application Number
761099
Product Number
1
Dosage Form
-
Strength
100MG/4ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ZIRABEV
Product Number
2
Dosage Form
-
Strength
400MG/16ML
Approval Date
-
Active Ingredient
BEVACIZUMAB-BVZR
Application Number
761099
Product Number
2
Dosage Form
-
Strength
400MG/16ML
Approval Date
-
Regulatory Status
Unclassified
Drug Name
ZOLEDRONIC ACID
Product Number
1
Dosage Form
-
Strength
4MG/5ML
Approval Date
-
Active Ingredient
ZOLEDRONIC ACID
Application Number
203344
Product Number
1
Dosage Form
-
Strength
4MG/5ML
Approval Date
-
Regulatory Status
Unclassified
Drug Status Breakdown
35 total- Unclassified
Official Source
FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.
Visit FDA Orange BookFDA Approved Drug Record Details Preview
Explore important FDA approved drug information available in the records above.
Drug Name
ABRILADA
Application Number
761118
Product Number
1
Active Ingredient
ADALIMUMAB-AFZB
Dosage Form
-
Strength
40MG/0.8ML
FDA Approved Drug Data
Approved drug product information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized FDA drug records
Create a New Buying Request
Fields marked with * are mandatory.